Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Applied Molecular Transport Inc stock

Learn how to easily invest in Applied Molecular Transport Inc stock.

Applied Molecular Transport Inc is a biotechnology business based in the US. Applied Molecular Transport Inc shares (AMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Molecular Transport Inc employs 125 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Applied Molecular Transport Inc

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMTI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Applied Molecular Transport Inc stock price (NASDAQ: AMTI)

Use our graph to track the performance of AMTI stocks over time.

Applied Molecular Transport Inc shares at a glance

Information last updated 2022-09-26.
Latest market close$0.98
52-week range$1.02 - $28.32
50-day moving average $1.70
200-day moving average $5.61
Wall St. target price$12.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.18

Buy Applied Molecular Transport Inc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Applied Molecular Transport Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied Molecular Transport Inc price performance over time

Historical closes compared with the close of $0.98 from 2022-09-29

1 week (2022-09-23) -12.50%
1 month (2022-09-01) -27.94%
3 months (2022-07-01) -66.21%
6 months (2022-03-28) N/A
1 year (2021-09-30) -96.21%
2 years (2020-10-01) -96.83%
3 years (2019-09-27) N/A
5 years (2017-09-27) N/A

Applied Molecular Transport Inc financials

Gross profit TTM $-30,105,000
Return on assets TTM -44.17%
Return on equity TTM -88.09%
Profit margin 0%
Book value $2.51
Market capitalisation $43 million

TTM: trailing 12 months

Applied Molecular Transport Inc share dividends

We're not expecting Applied Molecular Transport Inc to pay a dividend over the next 12 months.

Applied Molecular Transport Inc share price volatility

Over the last 12 months, Applied Molecular Transport Inc's shares have ranged in value from as little as $1.02 up to $28.32. A popular way to gauge a stock's volatility is its "beta".

AMTI.US volatility(beta: 1.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Molecular Transport Inc's is 1.2957. This would suggest that Applied Molecular Transport Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Applied Molecular Transport Inc overview

Applied Molecular Transport Inc. , a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Frequently asked questions

What percentage of Applied Molecular Transport Inc is owned by insiders or institutions?
Currently 22.892% of Applied Molecular Transport Inc shares are held by insiders and 62.053% by institutions.
How many people work for Applied Molecular Transport Inc?
Latest data suggests 125 work at Applied Molecular Transport Inc.
When does the fiscal year end for Applied Molecular Transport Inc?
Applied Molecular Transport Inc's fiscal year ends in December.
Where is Applied Molecular Transport Inc based?
Applied Molecular Transport Inc's address is: 450 East Jamie Court, South San Francisco, CA, United States, 94080
What is Applied Molecular Transport Inc's ISIN number?
Applied Molecular Transport Inc's international securities identification number is: US03824M1099

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site